- Title: Subtitle
- Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma
- Creators
- Matthew E Stokes - Bristol-Myers Squibb (United States)Kerstin Wenzl - Mayo ClinicC. Chris Huang - Bristol-Myers Squibb (United States)Maria Ortiz EstevezMatthew J. Maurer - Mayo ClinicNicholas Stong - Bristol-Myers Squibb (United States)Patrick Hagner - Bristol-Myers Squibb (United States)Yumi Nakayama - Bristol-Myers Squibb (United States)Chih-Chao Hsu - Bristol-Myers Squibb (United States)Samuel A Danziger - Bristol-Myers Squibb (United States)Fadi Towfic - Bristol-Myers Squibb (United States)Rebecca L. King - Mayo ClinicJoel S. Parker - Research Triangle Park FoundationBrian K. Link - University of IowaSusan L. Slager - Mayo ClinicVivekananda Sarangi - Mayo ClinicYan Asmann - Mayo Clinic in FloridaJoseph P. Novak - Mayo ClinicAkshay Sudhindra - Bristol-Myers Squibb (United States)Stephen M. Ansell - Mayo ClinicThomas M. Habermann - Mayo ClinicGrzegorz S. Nowakowski - Mayo ClinicJames R. Cerhan - Mayo ClinicAnne J. Novak - Mayo ClinicAnita K. Gandhi - Bristol-Myers Squibb (United States)
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.140(Supplement 1), pp.3548-3550
- DOI
- 10.1182/blood-2022-170228
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Language
- English
- Date published
- 11/15/2022
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984362668902771
Abstract
Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma
Blood, Vol.140(Supplement 1), pp.3548-3550
11/15/2022
DOI: 10.1182/blood-2022-170228
Details
Metrics
15 Record Views